Cybin (HELP) Receivables (2021 - 2026)
Cybin (HELP) posted quarterly Receivables of $5.0 million for Q1 2026, up 22.59% year-on-year from $4.1 million in Q1 2025, and up 5.5% on a QoQ basis from $4.8 million in Q4 2025.
Cybin (HELP) Receivables (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Receivables for 6 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- Quarterly Receivables rose 22.59% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 22.59% YoY) and the FY2026 annual result came in at $5.0 million, up 18.77% from the prior year.
- Receivables rose to $5.0 million in Q1 2026 per HELP's latest filing, from $4.8 million in the prior quarter.
- Over the last five years, Receivables for HELP reached as high as $5.0 million in Q1 2026 and fell as low as $900271.9 in Q1 2023.
- A 5-year average of $3.4 million and a median of $3.4 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables gained 11.29% — and 2023, when it surged 63.4%.
- Year by year, Receivables stood at $1.9 million in 2022, then jumped by 63.4% to $3.1 million in 2023, then gained by 27.84% to $4.0 million in 2024, then increased by 19.25% to $4.8 million in 2025, then advanced by 5.5% to $5.0 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $5.0 million, $4.8 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 4.11 Mn |
| Mar 31, 2025 | 4.10 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.04 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Feb 28, 2023 | 900,271.88 |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.36 Mn |
| Mar 31, 2021 | 1.05 Mn |